Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
NASDAQ:NKGN
NKGen Biotech (NKGN) Stock Price & Analysis
23 Followers
NKGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.78 - $12.88
Previous Close$0.86
Volume350.13K
Average Volume (3M)2.86M
Market Cap
$19.61M
Enterprise Value$30.85M
Total Cash (Recent Filing)$8.80M
Total Debt (Recent Filing)$20.04M
Price to Earnings (P/E)-0.2
Beta-0.32
Next Earnings
Nov 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.10
Shares Outstanding22,805,643
10 Day Avg. Volume188,830
30 Day Avg. Volume2,864,319
Standard Deviation0.30
R-Squared0.00889
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.65
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NKGen Biotech News
Ownership Overview
68.24% Insiders
1.35% Mutual Funds
2.84% Other Institutional Investors
27.57% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NKGN FAQ
What was NKGen Biotech’s price range in the past 12 months?
NKGen Biotech lowest stock price was $0.78 and its highest was $12.88 in the past 12 months.
What is NKGen Biotech’s market cap?
Currently, no data Available
When is NKGen Biotech’s upcoming earnings report date?
NKGen Biotech’s upcoming earnings report date is Nov 14, 2023 which is 173 days ago.
How were NKGen Biotech’s earnings last quarter?
Currently, no data Available
Is NKGen Biotech overvalued?
According to Wall Street analysts NKGen Biotech’s price is currently Overvalued.
Does NKGen Biotech pay dividends?
NKGen Biotech does not currently pay dividends.
What is NKGen Biotech’s EPS estimate?
NKGen Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NKGen Biotech have?
NKGen Biotech has 22,805,643 shares outstanding.
What happened to NKGen Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NKGen Biotech?
Among the largest hedge funds holding NKGen Biotech’s share is Fir Tree Inc.. It holds NKGen Biotech’s shares valued at N/A.
---
NKGen Biotech Stock Smart Score
Company Description
NKGen Biotech
Graf Acquisition Corp IV is a newly organized blank check company. It is formed for the purpose of effecting into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.
---
Technical Analysis
---